Lv11
100 积分 2024-08-08 加入
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1
1小时前
已完结
Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics
1小时前
已完结
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents
2小时前
已完结
Expanded Utility of the β-Glucuronide Linker: ADCs That Deliver Phenolic Cytotoxic Agents
4小时前
已完结
Toward a Ferrous Iron-Cleavable Linker for Antibody-Drug Conjugates
1天前
已完结
Payload diversification: a key step in the development of antibody–drug conjugates
2天前
已完结
New payloads drive next-gen antibody–drug conjugates
2天前
已完结
Antibody drug conjugates beyond cytotoxic payloads
2天前
已完结
Design and Synthesis of USP1 Inhibitors: Synergistic Antitumor Activity with PARP Inhibitors in Triple-Negative Breast Cancer
3天前
已完结
Discovery and Optimization of Novel Tricyclic Ubiquitin-Specific Protease 1 Inhibitors for the Treatment of BRCA-Mutated Breast Cancer
3天前
已完结
皖公网安备34019202002308
